XOMA Royalty (XOMA) Change in Receivables (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Change in Receivables came in at -$325000.0 in Q1 2026, down 108.77% year-on-year from $3.7 million in Q1 2025, and down 126.23% quarter-over-quarter from $1.2 million in Q4 2025.

XOMA Royalty (XOMA) Change in Receivables (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Change in Receivables across 17 years of filings, most recently posting -$325000.0 for Q1 2026.

  • Change in Receivables for Q1 2026 came in at -$325000.0, down 108.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.6 million (down 128.95% YoY), and the FY2025 annual result was $2.4 million, up 190.54% from the prior year.
  • Change in Receivables came in at -$325000.0 for Q1 2026 at XOMA Royalty, down from $1.2 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $3.7 million in Q1 2025 to a low of -$3.7 million in Q2 2025.
  • The 5-year median for Change in Receivables is $11000.0 (2022), against an average of $219470.6.
  • Across the five-year window, Change in Receivables soared 6506.67% in 2023 and plunged 20120.0% in 2024, its largest moves.
  • XOMA Royalty's Change in Receivables stood at -$15000.0 in 2022, then jumped by 6506.67% to $961000.0 in 2023, then fell by 17.38% to $794000.0 in 2024, then surged by 56.05% to $1.2 million in 2025, then tumbled by 126.23% to -$325000.0 in 2026.
  • The last three Change in Receivables figures came in at -$325000.0 (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 22,529.00
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -39.80 Mn
9 Abivax 95.45 Bn 95.45 Bn - -4.08 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - -325,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -325,000.00
Mar 31, 2026 -325,000.00
Dec 31, 2025 1.24 Mn
Dec 31, 2025 1.24 Mn
Sep 30, 2025 1.21 Mn
Sep 30, 2025 1.21 Mn
Jun 30, 2025 -3.73 Mn
Jun 30, 2025 -3.73 Mn
Mar 31, 2025 3.71 Mn
Mar 31, 2025 3.71 Mn
Dec 31, 2024 794,000.00
Dec 31, 2024 794,000.00
Sep 30, 2024 519,000.00
Sep 30, 2024 519,000.00
Jun 30, 2024 523,000.00
Jun 30, 2024 523,000.00
Mar 31, 2024 -1.00 Mn
Mar 31, 2024 -1.00 Mn
Dec 31, 2023 961,000.00
Dec 31, 2023 961,000.00